Boston Scientific to acquire Rubicon at lower price
This article was originally published in Clinica
Executive Summary
Boston Scientific has exercised an option to acquire the shares of the principal stockholders of Salt Lake City, Utah-based Rubicon Medical, giving it 53.6% ownership of the company. This triggered its obligation to launch a cash tend offer for the remaining shares.